Abbvie Inc banner

Abbvie Inc
BMV:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
BMV:ABBV
Watchlist
Price: 4 500 MXN 1.51%
Market Cap: Mex$409B

Wall St Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 4 557.89 MXN with a low forecast of 3 476.13 MXN and a high forecast of 6 023.92 MXN.

Lowest Forecast
Price Target
3 476.13 MXN
23% Downside
Average Forecast
Price Target
4 557.89 MXN
1% Upside
Highest Forecast
Price Target
6 023.92 MXN
34% Upside
Abbvie Inc Competitors:
Price Targets
AYTU
Aytu Biopharma Inc
331% Upside
NWSA
News Corp
33% Upside
AREC
American Resources Corp
224% Upside
ULTA
Ulta Beauty Inc
41% Upside

Revenue
Forecast

9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.

Gross Profit
Forecast

9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.

Operating Income
Forecast

12% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
12% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 12%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
81% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss
4% / Year
Past Growth
81% / Year
Estimated Growth
Estimates Accuracy
-51%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 81%.

Net Income
Forecast

1% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
1% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 31%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABBV's stock price target?
Price Target
4 557.89 MXN

According to Wall Street analysts, the average 1-year price target for ABBV is 4 557.89 MXN with a low forecast of 3 476.13 MXN and a high forecast of 6 023.92 MXN.

What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.

What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 12%.

What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
81%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 81%.

What is the Net Income forecast for Abbvie Inc?
Projected CAGR
31%

Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett